Traditional classifications categorize atrial fibrillation (AF) into paroxysmal, persistent, or permanent, but recent advancements in monitoring have revealed AF as a continuous variable, challenging existing paradigms. AF burden, defined basically as the amount of time spent in AF during a monitored period, has emerged as a crucial metric. This review assesses the evolving landscape of AF burden and its measurement methods, diagnostic modalities, and impact on outcomes. Guidelines suggest individualized approaches, combining AF burden with clinical scores (CHA2DS2-VASc), but studies have challenged this. Addressing the impact of AF burden on patients' quality of life before or after ablation is also crucial. Although continuous monitoring technologies offer promising avenues, the field faces challenges, such as defining clinically relevant thresholds. Future research should focus on refining these, designing trials centered around AF burden, and evaluating the efficacy of interventions in reducing AF burden, ultimately paving the way for personalized management strategies.
Atrial fibrillation burden: Stepping beyond the categorical characterization / Doundoulakis, I.; Nedios, S.; Zafeiropoulos, S.; Vitolo, M.; Della Rocca, D. G.; Kordalis, A.; Shamloo, A. S.; Koliastasis, L.; Marcon, L.; Chiotis, S.; Sorgente, A.; Soulaidopoulos, S.; Imberti, J. F.; Botis, M.; Pannone, L.; Gatzoulis, K. A.; Sarkozy, A.; Stavrakis, S.; Boriani, G.; Boveda, S.; Tsiachris, D.; Chierchia, G. -B.; de Asmundis, C.. - In: HEART RHYTHM. - ISSN 1547-5271. - (2024), pp. N/A-N/A. [10.1016/j.hrthm.2024.08.051]
Atrial fibrillation burden: Stepping beyond the categorical characterization
Vitolo M.;Imberti J. F.;Boriani G.;
2024
Abstract
Traditional classifications categorize atrial fibrillation (AF) into paroxysmal, persistent, or permanent, but recent advancements in monitoring have revealed AF as a continuous variable, challenging existing paradigms. AF burden, defined basically as the amount of time spent in AF during a monitored period, has emerged as a crucial metric. This review assesses the evolving landscape of AF burden and its measurement methods, diagnostic modalities, and impact on outcomes. Guidelines suggest individualized approaches, combining AF burden with clinical scores (CHA2DS2-VASc), but studies have challenged this. Addressing the impact of AF burden on patients' quality of life before or after ablation is also crucial. Although continuous monitoring technologies offer promising avenues, the field faces challenges, such as defining clinically relevant thresholds. Future research should focus on refining these, designing trials centered around AF burden, and evaluating the efficacy of interventions in reducing AF burden, ultimately paving the way for personalized management strategies.Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris